⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of SeerPharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
SeerPharma
↗Box Hill, Victoria, Australia
SeerPharma is a leading provider of technical compliance, Quality Assurance (QA), and Good Manufacturing Practice (GMP) consulting, training, and software solutions for the pharmaceutical, medical device, and biotechnology industries. Founded in 1989, the company supports organizations across the Asia-Pacific region with services ranging from R&D through to commercial manufacture, including inspection readiness for regulators like the TGA, US FDA, and EMA.
In addition to consulting and auditing, SeerPharma provides electronic Quality Management System (eQMS) implementation (notably using MasterControl software) and supplies short-term QA contractors. They are also known for their educational initiatives, including a postgraduate GMP program developed in partnership with the University of Technology Sydney (UTS).
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:-
Industry:CRO
Sub-Industry:Quality Assurance and Regulatory Compliance Consulting
SIZE & FINANCIALS
Employees:1-50
Founded:1989
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Subsidiaries:SeerPharma (Singapore) Pte. Ltd., SeerPharma (UK)
Key Partnerships:MasterControl (Software solutions provider), University of Technology Sydney (Academic partner for Postgraduate GMP program)
COMPETITION
Position:Niche Player
Competitors:Indegene, IntegriChain, Zuellig Pharma
LEADERSHIP
Key Executives:
Andrew Giles - Director / Senior Consultant
Biju Kishor - Consultant
LINKS
Website:seerpharma.com.au
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SeerPharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.